Roche Holding is trading at CHF 370.70, up 3.03%, as healthcare shares benefit from UnitedHealth’s Q3 earnings beat and raised 2026 outlook.
- Roche’s October 13 licensing deal gives it worldwide rights to Rona Therapeutics’ experimental obesity drug.
- Available reporting does not directly link the deal to the October 14 share move; a company-specific cause is unconfirmed.